I wanted to take a moment, post-APhA2025, to introduce myself to anyone who might not know me. It is the honor of a lifetime to serve as APhA’s president. I have spent my life preparing for this leadership role; as a co-owner and CEO of Towncrest Pharmacy Corporation, co-founder and co-owner of Innovative Pharmacy Solutions and professor of pharmacy management and innovation at Loma Linda University School of Pharmacy. 

Washington, D.C. —The American Pharmacists Association (APhA) is pleased to announce the appointment of Brian Lawson, PharmD, ICE-CCP, as Executive Director of the Board of Pharmacy Specialties (BPS), an autonomous division of APhA and the premier post-licensure certification body for the pharmacy profession. Lawson’s selection follows an exhaustive national search launched earlier this year to identify the next leader of BPS.

On November 15, DEA announced the extension of current telemedicine flexibilities for prescription-controlled medications through the end of 2025. This includes substances such as buprenorphine and Adderall.

Resting heart rate was associated with an increased risk of new-onset AFib for Black adults, according to a recent study published in JAMA Network Open.